Published in Cell Metab on April 01, 2009
Prader-Willi Syndrome Macronutrient Study | NCT02011360
Effect of Insulin Resistance on Branched Chain Amino Acid Metabolism. (BCAA) | NCT04886973
mTOR: from growth signal integration to cancer, diabetes and ageing. Nat Rev Mol Cell Biol (2010) 21.16
Metabolite profiles and the risk of developing diabetes. Nat Med (2011) 12.22
Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science (2013) 8.81
Relationships between circulating metabolic intermediates and insulin action in overweight to obese, inactive men and women. Diabetes Care (2009) 3.69
Interplay between lipids and branched-chain amino acids in development of insulin resistance. Cell Metab (2012) 3.26
Leptin therapy in insulin-deficient type I diabetes. Proc Natl Acad Sci U S A (2010) 3.23
Differential metabolic impact of gastric bypass surgery versus dietary intervention in obese diabetic subjects despite identical weight loss. Sci Transl Med (2011) 3.20
Elevation of circulating branched-chain amino acids is an early event in human pancreatic adenocarcinoma development. Nat Med (2014) 3.09
Autophagy in the cellular energetic balance. Cell Metab (2011) 3.06
Next-generation mTOR inhibitors in clinical oncology: how pathway complexity informs therapeutic strategy. J Clin Invest (2011) 3.00
Insulin resistance is associated with a metabolic profile of altered protein metabolism in Chinese and Asian-Indian men. Diabetologia (2010) 2.99
alpha-hydroxybutyrate is an early biomarker of insulin resistance and glucose intolerance in a nondiabetic population. PLoS One (2010) 2.94
β-Aminoisobutyric acid induces browning of white fat and hepatic β-oxidation and is inversely correlated with cardiometabolic risk factors. Cell Metab (2014) 2.86
Prepregnancy dietary protein intake, major dietary protein sources, and the risk of gestational diabetes mellitus: a prospective cohort study. Diabetes Care (2013) 2.81
Metabolomics applied to diabetes research: moving from information to knowledge. Diabetes (2009) 2.68
Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future. Lancet (2013) 2.66
Identification of serum metabolites associated with risk of type 2 diabetes using a targeted metabolomic approach. Diabetes (2012) 2.62
The role of mitochondria in the pathogenesis of type 2 diabetes. Endocr Rev (2010) 2.59
Metabolite profiling identifies pathways associated with metabolic risk in humans. Circulation (2012) 2.51
Novel biomarkers for pre-diabetes identified by metabolomics. Mol Syst Biol (2012) 2.39
Amino acids and mTORC1: from lysosomes to disease. Trends Mol Med (2012) 2.38
Metabolic pathways promoting cancer cell survival and growth. Nat Cell Biol (2015) 2.35
Increased levels of plasma acylcarnitines in obesity and type 2 diabetes and identification of a marker of glucolipotoxicity. Obesity (Silver Spring) (2010) 2.23
The emerging role of autophagy in the pathophysiology of diabetes mellitus. Autophagy (2011) 2.18
2-Aminoadipic acid is a biomarker for diabetes risk. J Clin Invest (2013) 2.15
Plasma metabolomic profiles reflective of glucose homeostasis in non-diabetic and type 2 diabetic obese African-American women. PLoS One (2010) 2.14
Muscle-specific deletion of carnitine acetyltransferase compromises glucose tolerance and metabolic flexibility. Cell Metab (2012) 2.11
Sialylated Milk Oligosaccharides Promote Microbiota-Dependent Growth in Models of Infant Undernutrition. Cell (2016) 2.06
Regulation of insulin sensitivity by serine/threonine phosphorylation of insulin receptor substrate proteins IRS1 and IRS2. Diabetologia (2012) 2.05
An Essential Role of the Mitochondrial Electron Transport Chain in Cell Proliferation Is to Enable Aspartate Synthesis. Cell (2015) 2.03
The role of mitochondria in insulin resistance and type 2 diabetes mellitus. Nat Rev Endocrinol (2011) 2.02
Emerging perspectives on essential amino acid metabolism in obesity and the insulin-resistant state. Adv Nutr (2011) 2.01
Branched-chain and aromatic amino acids are predictors of insulin resistance in young adults. Diabetes Care (2012) 1.98
The metabolic footprint of aging in mice. Sci Rep (2011) 1.93
Branched-chain amino acid levels are associated with improvement in insulin resistance with weight loss. Diabetologia (2011) 1.93
Metabolic signatures of insulin resistance in 7,098 young adults. Diabetes (2012) 1.80
Adipose tissue branched chain amino acid (BCAA) metabolism modulates circulating BCAA levels. J Biol Chem (2010) 1.80
Hyperglycemia and a common variant of GCKR are associated with the levels of eight amino acids in 9,369 Finnish men. Diabetes (2012) 1.78
Plasma metabolomic profile in nonalcoholic fatty liver disease. Metabolism (2010) 1.77
Dietary leucine--an environmental modifier of insulin resistance acting on multiple levels of metabolism. PLoS One (2011) 1.74
Protein Ingestion Induces Muscle Insulin Resistance Independent of Leucine-Mediated mTOR Activation. Diabetes (2014) 1.72
Branched-chain amino acids in metabolic signalling and insulin resistance. Nat Rev Endocrinol (2014) 1.71
Circulating branched-chain amino acid concentrations are associated with obesity and future insulin resistance in children and adolescents. Pediatr Obes (2012) 1.69
Downregulation of AMPK accompanies leucine- and glucose-induced increases in protein synthesis and insulin resistance in rat skeletal muscle. Diabetes (2010) 1.64
Metabolomic profiling for the identification of novel biomarkers and mechanisms related to common cardiovascular diseases: form and function. Circulation (2012) 1.64
A branched-chain amino acid metabolite drives vascular fatty acid transport and causes insulin resistance. Nat Med (2016) 1.63
Metabolite profiling identifies markers of uremia. J Am Soc Nephrol (2010) 1.63
Early metabolic markers of the development of dysglycemia and type 2 diabetes and their physiological significance. Diabetes (2012) 1.63
Mass spectrometry strategies in metabolomics. J Biol Chem (2011) 1.60
Regulation of adipose branched-chain amino acid catabolism enzyme expression and cross-adipose amino acid flux in human obesity. Am J Physiol Endocrinol Metab (2013) 1.58
Circulating metabolite predictors of glycemia in middle-aged men and women. Diabetes Care (2012) 1.57
Macronutrient balance and lifespan. Aging (Albany NY) (2009) 1.57
Leucine deprivation increases hepatic insulin sensitivity via GCN2/mTOR/S6K1 and AMPK pathways. Diabetes (2011) 1.55
Acylcarnitines: reflecting or inflicting insulin resistance? Diabetes (2013) 1.54
Metabolomics reveals signature of mitochondrial dysfunction in diabetic kidney disease. J Am Soc Nephrol (2013) 1.49
A diabetes-predictive amino acid score and future cardiovascular disease. Eur Heart J (2012) 1.47
Gut feelings about diabetes. Endocrinol Nutr (2012) 1.46
Biomarkers for type 2 diabetes and impaired fasting glucose using a nontargeted metabolomics approach. Diabetes (2013) 1.44
Global biochemical profiling identifies β-hydroxypyruvate as a potential mediator of type 2 diabetes in mice and humans. Diabetes (2014) 1.42
Metabolic signatures of adiposity in young adults: Mendelian randomization analysis and effects of weight change. PLoS Med (2014) 1.42
Famine versus feast: understanding the metabolism of tumors in vivo. Trends Biochem Sci (2015) 1.42
Plasma metabolomic profiles enhance precision medicine for volunteers of normal health. Proc Natl Acad Sci U S A (2015) 1.41
A systems biology approach identifies inflammatory abnormalities between mouse strains prior to development of metabolic disease. Diabetes (2010) 1.41
Multi-tissue, selective PPARγ modulation of insulin sensitivity and metabolic pathways in obese rats. Am J Physiol Endocrinol Metab (2010) 1.38
Metabolic signature of CKD: the search continues. Am J Kidney Dis (2012) 1.38
What is metabolic syndrome, and why are children getting it? Ann N Y Acad Sci (2013) 1.38
Defects in muscle branched-chain amino acid oxidation contribute to impaired lipid metabolism. Mol Metab (2016) 1.38
Toward a unifying hypothesis of metabolic syndrome. Pediatrics (2012) 1.36
A metabolic signature of long life in Caenorhabditis elegans. BMC Biol (2010) 1.36
Metabolomics and cardiovascular biomarker discovery. Clin Chem (2011) 1.36
Altered mitochondrial function and metabolic inflexibility associated with loss of caveolin-1. Cell Metab (2012) 1.35
Intramuscular triacylglycerol and insulin resistance: guilty as charged or wrongly accused? Biochim Biophys Acta (2009) 1.34
Do we really know why diabetes remits after gastric bypass surgery? Endocrine (2011) 1.32
Dysregulation of fatty acid synthesis and glycolysis in non-Hodgkin lymphoma. Proc Natl Acad Sci U S A (2012) 1.32
Regulation of substrate utilization by the mitochondrial pyruvate carrier. Mol Cell (2014) 1.30
Amino acids activate mammalian target of rapamycin complex 2 (mTORC2) via PI3K/Akt signaling. J Biol Chem (2010) 1.30
Thyroid hormone stimulates hepatic lipid catabolism via activation of autophagy. J Clin Invest (2012) 1.29
Metabolomic profiling of fatty acid and amino acid metabolism in youth with obesity and type 2 diabetes: evidence for enhanced mitochondrial oxidation. Diabetes Care (2012) 1.27
Metabolomic profiling reveals mitochondrial-derived lipid biomarkers that drive obesity-associated inflammation. PLoS One (2012) 1.27
Targeted metabolomics. Curr Protoc Mol Biol (2012) 1.24
Human metabolic correlates of body mass index. Metabolomics (2014) 1.24
Metabolite profiling identifies candidate markers reflecting the clinical adaptations associated with Roux-en-Y gastric bypass surgery. PLoS One (2009) 1.22
The contrasting roles of PPARδ and PPARγ in regulating the metabolic switch between oxidation and storage of fats in white adipose tissue. Genome Biol (2011) 1.22
mTOR inhibitors synergize on regression, reversal of gene expression, and autophagy in hepatocellular carcinoma. Sci Transl Med (2012) 1.21
Homeostatic regulation of protein intake: in search of a mechanism. Am J Physiol Regul Integr Comp Physiol (2012) 1.21
Leucine deprivation decreases fat mass by stimulation of lipolysis in white adipose tissue and upregulation of uncoupling protein 1 (UCP1) in brown adipose tissue. Diabetes (2009) 1.20
Branched chain amino acids are novel biomarkers for discrimination of metabolic wellness. Metabolism (2013) 1.20
Gene-environment and gene-treatment interactions in type 2 diabetes: progress, pitfalls, and prospects. Diabetes Care (2013) 1.20
mTORC1 activates SREBP-1c and uncouples lipogenesis from gluconeogenesis. Proc Natl Acad Sci U S A (2010) 1.20
Alanine and aspartate aminotransferase and glutamine-cycling pathway: their roles in pathogenesis of metabolic syndrome. World J Gastroenterol (2012) 1.19
Branched-chain amino acid metabolism in heart disease: an epiphenomenon or a real culprit? Cardiovasc Res (2011) 1.18
Metabolic network topology reveals transcriptional regulatory signatures of type 2 diabetes. PLoS Comput Biol (2010) 1.18
Omega-3 polyunsaturated fatty acids augment the muscle protein anabolic response to hyperinsulinaemia-hyperaminoacidaemia in healthy young and middle-aged men and women. Clin Sci (Lond) (2011) 1.17
The role of mammalian sirtuins in the regulation of metabolism, aging, and longevity. Handb Exp Pharmacol (2011) 1.16
The multifaceted role of mTORC1 in the control of lipid metabolism. EMBO Rep (2012) 1.16
Chronic leucine supplementation improves glycemic control in etiologically distinct mouse models of obesity and diabetes mellitus. Nutr Metab (Lond) (2010) 1.15
Urinary acylcarnitines are altered in human kidney cancer. Int J Cancer (2011) 1.14
A lipidomics analysis of the relationship between dietary fatty acid composition and insulin sensitivity in young adults. Diabetes (2012) 1.14
Klf15 orchestrates circadian nitrogen homeostasis. Cell Metab (2012) 1.14
International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc (2003) 47.83
Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002. JAMA (2004) 25.36
Inflammation and insulin resistance. J Clin Invest (2006) 18.76
Inflammation, stress, and diabetes. J Clin Invest (2005) 17.11
Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance. Cell Metab (2008) 9.74
Hypothalamic mTOR signaling regulates food intake. Science (2006) 8.62
Identification of a lipokine, a lipid hormone linking adipose tissue to systemic metabolism. Cell (2008) 7.37
Direct transesterification of all classes of lipids in a one-step reaction. J Lipid Res (1986) 6.42
Mechanisms of disease:Molecular and metabolic mechanisms of insulin resistance and beta-cell failure in type 2 diabetes. Nat Rev Mol Cell Biol (2008) 6.23
Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose. J Clin Invest (1981) 5.82
Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes (2002) 5.21
Hepatic expression of malonyl-CoA decarboxylase reverses muscle, liver and whole-animal insulin resistance. Nat Med (2004) 5.04
Nutrient overload, insulin resistance, and ribosomal protein S6 kinase 1, S6K1. Cell Metab (2006) 4.98
Molecular mechanisms of insulin resistance in humans and their potential links with mitochondrial dysfunction. Diabetes (2006) 4.95
Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation (1998) 4.89
The metabolic syndrome: is this diagnosis necessary? Am J Clin Nutr (2006) 4.35
Ceramides in insulin resistance and lipotoxicity. Prog Lipid Res (2005) 4.24
Identification of IRS-1 Ser-1101 as a target of S6K1 in nutrient- and obesity-induced insulin resistance. Proc Natl Acad Sci U S A (2007) 3.32
Disruption of BCATm in mice leads to increased energy expenditure associated with the activation of a futile protein turnover cycle. Cell Metab (2007) 3.30
Adipose tissue-derived factors: impact on health and disease. Endocr Rev (2006) 3.16
Mechanism of amino acid-induced skeletal muscle insulin resistance in humans. Diabetes (2002) 3.01
Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapy. Mol Psychiatry (2002) 2.87
Increasing dietary leucine intake reduces diet-induced obesity and improves glucose and cholesterol metabolism in mice via multimechanisms. Diabetes (2007) 2.85
Genetic networks of liver metabolism revealed by integration of metabolic and transcriptional profiling. PLoS Genet (2008) 2.63
Leptin signaling in the central nervous system and the periphery. Recent Prog Horm Res (2004) 2.62
Overactivation of S6 kinase 1 as a cause of human insulin resistance during increased amino acid availability. Diabetes (2005) 2.55
Tandem mass spectrometry: a new method for acylcarnitine profiling with potential for neonatal screening for inborn errors of metabolism. J Inherit Metab Dis (1990) 2.53
Validation of a new procedure to determine plasma fatty acid concentration and isotopic enrichment. J Lipid Res (1999) 2.50
Does leucine, leucyl-tRNA, or some metabolite of leucine regulate protein synthesis and degradation in skeletal and cardiac muscle? J Biol Chem (1982) 2.41
Insulin resistance of protein metabolism in type 2 diabetes. Diabetes (2007) 2.29
Potential importance of leucine in treatment of obesity and the metabolic syndrome. J Nutr (2006) 2.13
The Mammalian target of rapamycin pathway regulates nutrient-sensitive glucose uptake in man. Diabetes (2007) 2.09
ENU mutagenesis identifies mice with mitochondrial branched-chain aminotransferase deficiency resembling human maple syrup urine disease. J Clin Invest (2004) 2.08
Role of dietary proteins and amino acids in the pathogenesis of insulin resistance. Annu Rev Nutr (2007) 2.03
Direct and indirect effects of amino acids on hepatic glucose metabolism in humans. Diabetologia (2003) 2.02
Restoration of hypothalamic lipid sensing normalizes energy and glucose homeostasis in overfed rats. J Clin Invest (2006) 1.94
Molecular disruption of hypothalamic nutrient sensing induces obesity. Nat Neurosci (2006) 1.87
Obesity as a cardiovascular risk factor. Am J Med (2003) 1.86
Branched-chain amino acids and brain function. J Nutr (2005) 1.78
Obesity is a major determinant of the association of C-reactive protein levels and the metabolic syndrome in type 2 diabetes. Diabetes (2006) 1.75
Splanchnic glucose and amino acid metabolism in obesity. J Clin Invest (1974) 1.73
Rapid diagnosis of maple syrup urine disease in blood spots from newborns by tandem mass spectrometry. Clin Chem (1995) 1.62
The Study of the Effects of Diet on Metabolism and Nutrition (STEDMAN) weight loss project: Rationale and design. Contemp Clin Trials (2005) 1.57
Use of adjustment factors with a brief food frequency questionnaire to obtain nutrient values. Epidemiology (1990) 1.47
Determinants of whole-body protein metabolism in subjects with and without type 2 diabetes. Diabetes Care (2007) 1.45
Whole-body protein anabolic response is resistant to the action of insulin in obese women. Am J Clin Nutr (2005) 1.43
Growth hormone in obesity. Int J Obes Relat Metab Disord (1999) 1.43
Effect of weight loss on insulin sensitivity and intramuscular long-chain fatty acyl-CoAs in morbidly obese subjects. Diabetes (2002) 1.40
Biological, physiological, and pharmacological aspects of ghrelin. J Pharmacol Sci (2006) 1.30
Cardiovascular risk factors in primary care: methods and baseline prevalence rates--the DETECT program. Curr Med Res Opin (2005) 1.29
Roles of mTOR and JNK in serine phosphorylation, translocation, and degradation of IRS-1. Biochem Biophys Res Commun (2005) 1.26
The impact of obesity, fat distribution, and energy restriction on insulin-like growth factor-1 (IGF-1), IGF-binding protein-3, insulin, and growth hormone. Metabolism (1994) 1.12
Relationships between IGF-I and age, gender, body mass, fat distribution, metabolic and hormonal variables in obese patients. Int J Obes Relat Metab Disord (1999) 1.11
Insulin-induced stimulation of JNK and the PI 3-kinase/mTOR pathway leads to phosphorylation of serine 318 of IRS-1 in C2C12 myotubes. Biochem Biophys Res Commun (2005) 1.10
Twenty-four-hour plasma tryptophan concentrations and ratios are below normal in obese subjects and are not normalized by substantial weight reduction. Am J Clin Nutr (2003) 1.05
Low concentrations of insulin-like growth factor-I in abdominal obesity. Int J Obes Relat Metab Disord (1993) 1.04
Opposite associations of age-dependent insulin-like growth factor-I standard deviation scores with nutritional state in normal weight and obese subjects. Eur J Endocrinol (2006) 1.00
Effects of short-term administration of low-dose rhGH on IGF-I levels in obesity and Cushing's syndrome: indirect evaluation of sensitivity to GH. Eur J Endocrinol (2001) 0.94
Evidence for diminished brain 5-hydroxytryptamine biosynthesis in obese diabetic and non-diabetic humans. Am J Clin Nutr (1985) 0.90
A common variant on chromosome 9p21 affects the risk of myocardial infarction. Science (2007) 18.96
Effects of comprehensive lifestyle modification on blood pressure control: main results of the PREMIER clinical trial. JAMA (2003) 13.82
Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance. Cell Metab (2008) 9.74
Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science (2013) 8.81
Comparison of strategies for sustaining weight loss: the weight loss maintenance randomized controlled trial. JAMA (2008) 8.45
Large-scale association analysis identifies new risk loci for coronary artery disease. Nat Genet (2012) 7.59
Effects of the amount and intensity of exercise on plasma lipoproteins. N Engl J Med (2002) 7.34
Sequence variants affecting eosinophil numbers associate with asthma and myocardial infarction. Nat Genet (2009) 6.83
The same sequence variant on 9p21 associates with myocardial infarction, abdominal aortic aneurysm and intracranial aneurysm. Nat Genet (2008) 6.72
SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation. Nature (2010) 6.48
Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States. Gastroenterology (2008) 5.45
Nutrition therapy recommendations for the management of adults with diabetes. Diabetes Care (2013) 4.85
Effects of comprehensive lifestyle modification on diet, weight, physical fitness, and blood pressure control: 18-month results of a randomized trial. Ann Intern Med (2006) 4.66
Dissociation of hepatic steatosis and insulin resistance in mice overexpressing DGAT in the liver. Cell Metab (2007) 4.51
Peroxisome proliferator-activated receptor-gamma co-activator 1alpha-mediated metabolic remodeling of skeletal myocytes mimics exercise training and reverses lipid-induced mitochondrial inefficiency. J Biol Chem (2005) 4.30
Music, imagery, touch, and prayer as adjuncts to interventional cardiac care: the Monitoring and Actualisation of Noetic Trainings (MANTRA) II randomised study. Lancet (2005) 4.29
The impact of a consortium of fermented milk strains on the gut microbiome of gnotobiotic mice and monozygotic twins. Sci Transl Med (2011) 4.24
Effects of low-carbohydrate vs low-fat diets on weight loss and cardiovascular risk factors: a meta-analysis of randomized controlled trials. Arch Intern Med (2006) 4.19
Effect of platelet inhibition with cangrelor during PCI on ischemic events. N Engl J Med (2013) 4.16
Coding Variation in ANGPTL4, LPL, and SVEP1 and the Risk of Coronary Disease. N Engl J Med (2016) 3.88
Weight loss during the intensive intervention phase of the weight-loss maintenance trial. Am J Prev Med (2008) 3.79
Relationships between circulating metabolic intermediates and insulin action in overweight to obese, inactive men and women. Diabetes Care (2009) 3.69
2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation (2013) 3.63
Suppression of oxidative stress by β-hydroxybutyrate, an endogenous histone deacetylase inhibitor. Science (2012) 3.52
Drug-Induced Liver Injury Network (DILIN) prospective study: rationale, design and conduct. Drug Saf (2009) 3.48
2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2013) 3.35
SIRT3 deficiency and mitochondrial protein hyperacetylation accelerate the development of the metabolic syndrome. Mol Cell (2011) 3.33
Leptin therapy in insulin-deficient type I diabetes. Proc Natl Acad Sci U S A (2010) 3.23
Differential metabolic impact of gastric bypass surgery versus dietary intervention in obese diabetic subjects despite identical weight loss. Sci Transl Med (2011) 3.20
Effect of the volume and intensity of exercise training on insulin sensitivity. J Appl Physiol (1985) (2003) 3.18
Absence of the SRC-2 coactivator results in a glycogenopathy resembling Von Gierke's disease. Science (2008) 3.17
Two self-management interventions to improve hypertension control: a randomized trial. Ann Intern Med (2009) 3.13
The SLCO1B1*5 genetic variant is associated with statin-induced side effects. J Am Coll Cardiol (2009) 3.10
Hypothalamic CaMKK2 contributes to the regulation of energy balance. Cell Metab (2008) 3.04
Pompe disease diagnosis and management guideline. Genet Med (2006) 3.03
Genetic vulnerability to diet-induced obesity in the C57BL/6J mouse: physiological and molecular characteristics. Physiol Behav (2004) 3.00
Individual blood pressure responses to changes in salt intake: results from the DASH-Sodium trial. Hypertension (2003) 2.87
Predictors of proteinuria and renal failure among women with HIV infection. Kidney Int (2002) 2.83
Continuous electroencephalographic monitoring in critically ill patients: indications, limitations, and strategies. Crit Care Med (2013) 2.79
Effect of Allowing Choice of Diet on Weight Loss: A Randomized Trial. Ann Intern Med (2015) 2.70
Initial validation of a self-report measure of the extent of and reasons for medication nonadherence. Med Care (2012) 2.70
Metabolomics applied to diabetes research: moving from information to knowledge. Diabetes (2009) 2.68
Genetic networks of liver metabolism revealed by integration of metabolic and transcriptional profiling. PLoS Genet (2008) 2.63
The clinical epidemiology and course of the spectrum of renal diseases associated with HIV infection. Kidney Int (2004) 2.60
Circadian clock NAD+ cycle drives mitochondrial oxidative metabolism in mice. Science (2013) 2.49
Glycogen synthase kinase 3alpha and 3beta mediate a glucose-sensitive antiapoptotic signaling pathway to stabilize Mcl-1. Mol Cell Biol (2007) 2.45
Dissecting the in vivo metabolic potential of two human gut acetogens. J Biol Chem (2010) 2.42
Dance and reducing television viewing to prevent weight gain in African-American girls: the Stanford GEMS pilot study. Ethn Dis (2003) 2.41
Nitric oxide represses the Arabidopsis floral transition. Science (2004) 2.41
Obesity prevalence among veterans at Veterans Affairs medical facilities. Am J Prev Med (2005) 2.40
Hypertension improvement project: randomized trial of quality improvement for physicians and lifestyle modification for patients. Hypertension (2009) 2.37
Sex Differences in Demographics, Risk Factors, Presentation, and Noninvasive Testing in Stable Outpatients With Suspected Coronary Artery Disease: Insights From the PROMISE Trial. JACC Cardiovasc Imaging (2016) 2.36
Association of a peripheral blood metabolic profile with coronary artery disease and risk of subsequent cardiovascular events. Circ Cardiovasc Genet (2010) 2.34
Presence and severity of intensive care unit-acquired paresis at time of awakening are associated with increased intensive care unit and hospital mortality. Crit Care Med (2009) 2.31
Causality assessment in drug-induced liver injury using a structured expert opinion process: comparison to the Roussel-Uclaf causality assessment method. Hepatology (2010) 2.30
Carnitine insufficiency caused by aging and overnutrition compromises mitochondrial performance and metabolic control. J Biol Chem (2009) 2.28
Comparison of aerobic versus resistance exercise training effects on metabolic syndrome (from the Studies of a Targeted Risk Reduction Intervention Through Defined Exercise - STRRIDE-AT/RT). Am J Cardiol (2011) 2.28
Prospective evaluation of pain and analgesic use following major elective intracranial surgery. J Neurosurg (2007) 2.26
Mortality in patients with necrotizing fasciitis. Plast Reconstr Surg (2007) 2.25
Genetically determined height and coronary artery disease. N Engl J Med (2015) 2.24
High heritability of metabolomic profiles in families burdened with premature cardiovascular disease. Mol Syst Biol (2009) 2.21
Lack of association between the Trp719Arg polymorphism in kinesin-like protein-6 and coronary artery disease in 19 case-control studies. J Am Coll Cardiol (2010) 2.17
Sex differences in mortality following acute coronary syndromes. JAMA (2009) 2.17
Exercise training amount and intensity effects on metabolic syndrome (from Studies of a Targeted Risk Reduction Intervention through Defined Exercise). Am J Cardiol (2007) 2.14
An after-school obesity prevention program for African-American girls: the Minnesota GEMS pilot study. Ethn Dis (2003) 2.12
Muscle-specific deletion of carnitine acetyltransferase compromises glucose tolerance and metabolic flexibility. Cell Metab (2012) 2.11
Acute lung injury in critical neurological illness. Crit Care Med (2012) 2.09
Effect of 6-month adherence to a very low carbohydrate diet program. Am J Med (2002) 2.04
Fat, carbohydrate, and calories in the development of diabetes and obesity in the C57BL/6J mouse. Metabolism (2004) 2.04
A pyruvate cycling pathway involving cytosolic NADP-dependent isocitrate dehydrogenase regulates glucose-stimulated insulin secretion. J Biol Chem (2006) 2.03